Scholarlink

<p>Currently, cardiovascular diseases (CVDs) represent a substantial threat to human health and wellness. Accumulating evidence has increasingly highlighted the pivotal role of the DNA-activated cyclic GMP-AMP (cGAMP) synthase (cGAS)-stimulator of interferon gene (STING) pathway in the progression of CVDs. The enhanced type I interferon response and the release of pro-inflammatory mediators disrupt cellular redox balance and trigger various cell death modalities, potentially leading to the emergence of adverse events such as atherosclerosis. Importantly, pharmacological or genetic suppression of the cGAS-STING axis has shown promise in alleviating cardiac injury symptoms. Moderate activation of STING can elicit effective immune responses against myocardial virus infection. This review elucidates the biochemical properties of cGAS and STING, as well as the mechanistic insights into the cGAS-STING pathway within the cardiovascular system, emphasizing the therapeutic potential of cGAS-STING modulators for CVD management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Emerging role of the cGAS-STING pathway in cardiovascular diseases: biologic function, mechanisms and targeted therapy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月4日

查看全文
  • Junke Mou,
  • Yuwu Chen,
  • Xinxin Zhu,
  • Biyi Xu,
  • Mengyang Wang,
  • Jiani Xie,
  • Tong Lin,
  • Qishuo Gu,
  • Qiuwen Wu,
  • Ziao Che,
  • Ji Li,
  • Xing Luo,
  • Haibo Jia,
  • Bo Yu

摘要

Currently, cardiovascular diseases (CVDs) represent a substantial threat to human health and wellness. Accumulating evidence has increasingly highlighted the pivotal role of the DNA-activated cyclic GMP-AMP (cGAMP) synthase (cGAS)-stimulator of interferon gene (STING) pathway in the progression of CVDs. The enhanced type I interferon response and the release of pro-inflammatory mediators disrupt cellular redox balance and trigger various cell death modalities, potentially leading to the emergence of adverse events such as atherosclerosis. Importantly, pharmacological or genetic suppression of the cGAS-STING axis has shown promise in alleviating cardiac injury symptoms. Moderate activation of STING can elicit effective immune responses against myocardial virus infection. This review elucidates the biochemical properties of cGAS and STING, as well as the mechanistic insights into the cGAS-STING pathway within the cardiovascular system, emphasizing the therapeutic potential of cGAS-STING modulators for CVD management.